Publisher
Springer Science and Business Media LLC
Subject
Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Pathology and Forensic Medicine
Reference59 articles.
1. Zinn, D.J., R. Chakraborty, and C.E. Allen, Langerhans Cell Histiocytosis: Emerging Insights and Clinical Implications. Oncology (Williston Park), 2016. 30(2): p. 122–132, 139.
2. Grana, N., Langerhans cell histiocytosis. Cancer Control, 2014. 21(4): p. 328–334.
3. Badalian-Very, G., et al., Recurrent BRAF mutations in Langerhans cell histiocytosis. Blood, 2010. 116(11): p. 1919–1923.
4. Alayed, K., et al., BRAF and MAP2K1 mutations in Langerhans cell histiocytosis: a study of 50 cases. Hum Pathol, 2016. 52: p. 61–67.
5. Chakraborty, R., et al., Mutually exclusive recurrent somatic mutations in MAP2K1 and BRAF support a central role for ERK activation in LCH pathogenesis. Blood, 2014. 124(19): p. 3007–3015.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献